BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11446161)

  • 1. Structure-activity relationships of novel anti-malarial agents: 1. arylacyl and cyclohexylacyl derivatives of 5-amino-2-tolylacetylaminobenzophenone.
    Wiesner J; Mitsch A; Wissner P; Jomaa H; Schlitzer M
    Pharmazie; 2001 Jun; 56(6):443-4. PubMed ID: 11446161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of novel anti-malarial agents part 8. Effect of different central aryls in biarylacryloylaminobenzophenones on antimalarial activity.
    Wiesner J; Mitsch A; Altenkämper M; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2003 Dec; 58(12):854-6. PubMed ID: 14703959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-(aminoacylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
    Kettler K; Wiesner J; Fucik K; Sakowski J; Ortmann R; Dahse HM; Jomaa H; Schlitzer M
    Pharmazie; 2005 Sep; 60(9):677-82. PubMed ID: 16222868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
    Altenkämper M; Bechem B; Perruchon J; Heinrich S; Mädel A; Ortmann R; Dahse HM; Freunscht E; Wang Y; Rath J; Stich A; Hitzler M; Chiba P; Lanzer M; Schlitzer M
    Bioorg Med Chem; 2009 Nov; 17(22):7690-7. PubMed ID: 19819706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of novel anti-malarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides.
    Wiesner J; Kettler K; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2002 Feb; 12(4):543-5. PubMed ID: 11844668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Wiesner J; Fucik K; Kettler K; Sakowski J; Ortmann R; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 May; 13(9):1539-41. PubMed ID: 12699750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.
    Huang TL; Vanden Eynde JJ; Mayence A; Donkor IO; Khan SI; Tekwani BL
    J Pharm Pharmacol; 2006 Aug; 58(8):1033-42. PubMed ID: 16872549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives.
    Chiyanzu I; Clarkson C; Smith PJ; Lehman J; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem; 2005 May; 13(9):3249-61. PubMed ID: 15809160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and exploration of novel curcumin analogues as anti-malarial agents.
    Mishra S; Karmodiya K; Surolia N; Surolia A
    Bioorg Med Chem; 2008 Mar; 16(6):2894-902. PubMed ID: 18194869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials.
    Rodrigues T; Guedes RC; dos Santos DJ; Carrasco M; Gut J; Rosenthal PJ; Moreira R; Lopes F
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3476-80. PubMed ID: 19467600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of a novel series of indoloisoquinolines as small molecule anti-malarial leads.
    Horrocks P; Fallon S; Denman L; Devine O; Duffy LJ; Harper A; Meredith EL; Hasenkamp S; Sidaway A; Monnery D; Phillips TR; Allin SM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1770-3. PubMed ID: 22264480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasites.
    Heinrich S; Altenkämper M; Bechem B; Perruchon J; Ortmann R; Dahse HM; Wang Y; Lanzer M; Schlitzer M
    Eur J Med Chem; 2011 Apr; 46(4):1331-42. PubMed ID: 21345543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
    Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
    J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
    Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
    Musonda CC; Taylor D; Lehman J; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3901-5. PubMed ID: 15225694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonyl-phenyl-ureido benzamidines; a novel structural class of potent antimalarial agents.
    Leban J; Pegoraro S; Dormeyer M; Lanzer M; Aschenbrenner A; Kramer B
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1979-82. PubMed ID: 15050641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates.
    Haemers T; Wiesner J; Giessmann D; Verbrugghen T; Hillaert U; Ortmann R; Jomaa H; Link A; Schlitzer M; Van Calenbergh S
    Bioorg Med Chem; 2008 Mar; 16(6):3361-71. PubMed ID: 18158249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel lead structure for anti-malarials.
    Wiesner J; Wissner P; Dahse HM; Jomaa H; Schlitzer M
    Bioorg Med Chem; 2001 Mar; 9(3):785-92. PubMed ID: 11310613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.